FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreACR® submitted recommendations Oct. 27, to the White House Office of Science and Technology Policy the College asserts would enhance oversight and payment approaches to better accommodate emerging AI technologies. The College was responding to the government’s Request for Information (RFI) about regulatory reforms related to AI. This RFI, introduced as part of America’s AI Action Plan, seeks cross-sector input on strategies to accelerate AI innovation while addressing regulatory challenges.
ACR focused particularly on oversight approaches involving continuous learning systems and foundation model-based functions with novel safety and effectiveness considerations. Pertaining to CMS, the College emphasized the need for appropriate reimbursement policies that support qualified use of clinically valuable AI tools and account for associated costs such as governance, infrastructure, ongoing monitoring and training.
Among other suggestions, ACR advocated for harmonized transparency requirements across HHS agencies to foster trust and adoption of AI in clinical settings, and proposed clarifications to HIPAA requirements to support clinical site participation in AI performance monitoring programs.
To learn more about ACR’s leadership in radiology AI, visit the ACR Data Science Institute. For inquiries related to federal AI policy, contact Michael Peters, ACR Senior Director of Government Affairs.
FDA Highlights Programs for Innovators at ACR DSI Summit
The FDA joined the ACR®️ Data Science Summit June 9 to give an update about its Total Product Life Cycle Advisory Program.
Read moreLower Fee Now in Effect to File No Surprises Act Disputes
Federal agencies released a final rule that updates the No Surprises Act independent dispute resolution process. The rule lowers the IDR administrative or filing fee from $115 to $15.
Read moreACR Urges Funding for NIH All of Us Program
ACR urges Congress to provide dedicated funding for NIH’s All of Us Research Program, a leader in precision medicine technologies and a valuable tool for researchers.
Read more